Terazosin Hydrochloride
Product Images NDC 71610-840

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 71610-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0840 30)

Terazosin Hydrochloride 5 mg capsules, bottle label showing package size of 30 capsules. The label includes storage instructions to keep between 20-25 degrees Celsius and to dispense in a tight light-resistant container. The product is labeled for prescription use only and is manufactured by GSMS, Inc., with packaging by Aphena Pharma Solutions in Cookeville, TN.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Terazosinhydrochloridechemicalstructure (Chemicalstructure)

Chemical structure of Terazosin Hydrochloride, showing its molecular arrangement including methoxy groups, amine, piperazine ring, carbamate linkage, and hydrochloride salt.*

FDA Label Image

Figure1 (Figure1)

This image contains two line graphs comparing Terazosin and placebo effects over three months. The left graph shows mean change in total symptom score from baseline, with Terazosin showing greater reduction. The right graph presents mean increase in peak flow rate (mL/sec) from baseline, with Terazosin demonstrating higher increases compared to placebo.*

FDA Label Image

Figure2 (Figure2)

A line chart depicting mean change from baseline over 30 months. The x-axis represents time in months (0 to 30), and the y-axis shows mean change values, decreasing downward. Data points show a trend of decreasing values, stabilizing after approximately 6 months. Asterisks mark points of statistical significance.*

FDA Label Image

Figure3 (Figure3)

A line graph showing mean change from baseline over time in months, with data points from month 0 to 30. The y-axis represents the mean change value, while the x-axis shows the months. Error bars are included at each data point, and several points are marked with asterisks indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.